Study of Remdesivir in Participants Below 18 Years Old With COVID-19

Completed · Phase 2/Phase 3

Conditions studied: COVID-19

In brief

The goals of this clinical study are to learn more about the study drug, remdesivir, and how safe it is in participants less than 18 years old with coronavirus disease 2019 (COVID-19).

Key facts

Study ID
NCT04431453
Run by
Gilead Sciences
People needed
59
Starts
2020-07-21
Expected to finish
2023-02-10
Last updated by the study team
2024-02-06

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.